Oncology
ECOG Performance Status
Functional status in oncology.
Education and reference only. Not a substitute for clinical judgement, local policy or product labelling. Always verify before clinical use. Values are calculated in your browser and never stored.
Background
The Eastern Cooperative Oncology Group (ECOG) performance status is a simple scale describing a patient's level of functioning in terms of their ability to care for themselves and carry out daily activity. It runs from 0 (fully active, no restriction) through to 4 (completely disabled, confined to bed or chair) and 5 (dead). It is widely used in oncology to summarise overall fitness, to assess suitability for cancer treatments such as chemotherapy, and as an independent prognostic marker. A closely related scale, the Karnofsky Performance Status, conveys similar information on a 0–100 scale.
Interpreting the result
Scores of 0–1 indicate good performance status and generally support consideration of active anti-cancer treatment. A score of 2 marks meaningful restriction (ambulatory and self-caring but unable to work, up and about more than half the waking day), and treatment decisions become more nuanced. Scores of 3–4 reflect poor performance status, where the burden and toxicity of treatment often outweigh benefit, and the emphasis frequently shifts towards supportive and palliative care. Performance status is one of the strongest predictors of tolerance and outcome in cancer care.
Worked example
A patient with cancer spends most of the day resting but is up and about for short periods, manages their own washing and dressing, and is out of bed for less than half the waking day. This corresponds to ECOG 3 — limited self-care, confined to bed or chair for more than half of waking hours — which usually argues against intensive systemic therapy.
Pearls / pitfalls
- It is an assessment of usual function, not a single snapshot — a patient acutely unwell from a reversible problem may temporarily appear worse than their baseline.
- Performance status drives clinical-trial eligibility and real-world treatment decisions, so accurate, honest scoring matters.
- It can be discordant with patient-reported function; corroborate with history and, where helpful, objective measures.
- The boundary between ECOG 2 and 3 (more than half the waking day in bed/chair) is decision-critical for treatment intensity — assess it carefully.
Evidence & validation
Described by Oken and colleagues for the Eastern Cooperative Oncology Group, the scale is used across oncology trials and routine practice and is recognised as a robust prognostic and eligibility marker, including within trial inclusion criteria and treatment guidelines.
Frequently asked questions
What ECOG score is needed for cancer treatment?
Many systemic therapies are best suited to patients with ECOG 0–1, and decisions become more individualised at ECOG 2. At ECOG 3–4 the harms of treatment often outweigh benefit, and care commonly focuses on symptom control.
How does ECOG relate to the Karnofsky score?
Both describe performance status. ECOG uses a 0–5 scale and Karnofsky a 0–100 scale, and they correspond approximately — for example ECOG 0 maps to Karnofsky 90–100. They convey the same underlying information.
Why does performance status matter so much in oncology?
It is one of the strongest predictors of how well a patient will tolerate treatment and of overall prognosis. It therefore guides both eligibility for therapy and the balance between active and supportive care.
Should I score the patient on how they are today or usually?
Score their usual baseline function, taking care not to be misled by a temporary, reversible deterioration such as an acute infection. The aim is to capture their typical level of activity.
References
- Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655.
- National Comprehensive Cancer Network (NCCN) and ESMO guidelines reference ECOG performance status for treatment eligibility.
Related calculators
Need a calculator we don't have — or a custom tool?
We build evidence-led clinical calculators, dashboards and reference tools for teams.